FDA Opens a CMS-linked Side Door: Use of Digital Health Devices Before Authorization Under the TEMPO Pilot

Start
The U.S. Food and Drug Administration (FDA) announced the Technology-Enabled Meaningful Patient Outcomes for Digital Health Devices Pilot, or “TEMPO pilot,” on December 5, 2025, alongside a Federal Register notice seeking statements of interest for participation….
By: Hogan Lovells
Previous Story

CFTC Launches Digital Assets Pilot Program and Issues Guidance on Tokenized Collateral

Next Story

I Missed the Northern Lights Again, But the Insurance Industry Should Be Watching Carefully